Published in Int J Radiat Oncol Biol Phys on January 01, 1992
Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. Int J Radiat Oncol Biol Phys (2006) 1.18
Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local control. Radiother Oncol (2014) 0.83
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2). Eur J Nucl Med Mol Imaging (2014) 0.82
Rising variance: a leading indicator of ecological transition. Ecol Lett (2006) 5.94
Early warnings of regime shifts: a whole-ecosystem experiment. Science (2011) 3.64
Leading indicators of trophic cascades. Ecol Lett (2007) 2.25
Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol (1997) 2.02
Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg (1997) 2.01
A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys (1999) 1.89
The relative spatial distributions of CFUs and CFUc in the normal mouse femur. Blood (1975) 1.77
Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma. Ann Intern Med (1997) 1.71
The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiother Oncol (1993) 1.71
Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys (1995) 1.70
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys (1997) 1.70
Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung. Int J Radiat Oncol Biol Phys (1995) 1.70
Consequential late effects in normal tissues. Radiother Oncol (2001) 1.67
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. Int J Radiat Oncol Biol Phys (1996) 1.55
A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. Int J Radiat Oncol Biol Phys (1998) 1.55
Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.53
The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol (1992) 1.51
Time-dose factors in radiotherapy: a review of the human data. Radiother Oncol (1990) 1.51
Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am (1999) 1.48
Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am (1999) 1.47
A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys (1995) 1.44
Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys (1995) 1.42
The geographic relationships between physicians' residency sites and the locations of their first practices. Acad Med (1991) 1.42
Incorporating an understanding of independent practice physician culture into hospital structure and operations. Hosp Health Serv Adm (1992) 1.39
Predicting normal tissue response to radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.39
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys (1998) 1.34
Radioimmunoassay of the F prostaglandins. J Clin Endocrinol Metab (1971) 1.33
Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol (1989) 1.32
Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy. Anticancer Res (1985) 1.31
Purification of rat spermatogenic cells and preliminary biochemical analysis of these cells. Biol Reprod (1981) 1.29
Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. Int J Radiat Oncol Biol Phys (1996) 1.25
Biological effect of epidermal growth factor on the in vitro growth of human tumors. Cancer Res (1987) 1.25
Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res (2001) 1.24
Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol (1990) 1.23
Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther (2000) 1.23
Prostatic-specific antigen doubling times in patients with prostate cancer: a potentially useful reflection of tumor doubling time. Int J Radiat Oncol Biol Phys (1993) 1.21
Loss of atm radiosensitizes multiple p53 null tissues. Cancer Res (1998) 1.20
Extent and kinetics of recovery of occult spinal cord injury. Int J Radiat Oncol Biol Phys (2001) 1.20
Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys (1997) 1.18
A novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene (2010) 1.17
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol (1997) 1.17
Acute and late radiation injury in rhesus monkey parotid glands. Evidence of interphase cell death. Am J Pathol (1986) 1.16
Differential regeneration of intestinal proliferative cells and cryptogenic cells after irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 1.16
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer (1998) 1.15
Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol (1995) 1.14
Lack of correlation between residual radiation-induced DNA damage, in keratinocytes assayed directly from skin, and late radiotherapy reactions in breast cancer patients. Int J Radiat Oncol Biol Phys (1999) 1.13
Histone variants in rat spermatogonia and primary spermatocytes. Dev Biol (1985) 1.12
Early warnings of unknown nonlinear shifts: a nonparametric approach. Ecology (2011) 1.12
Megalourethra. J Urol (1986) 1.11
Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys (1998) 1.11
Long-term results with radiotherapy for Stage I-II follicular lymphomas. Int J Radiat Oncol Biol Phys (2001) 1.09
Letter: Clonogenic cells and stem cells in epidermis. Int J Radiat Biol Relat Stud Phys Chem Med (1973) 1.09
Initial slope of radiation survival curves is characteristic of the origin of primary and established cultures of human tumor cells and fibroblasts. Radiat Res (1987) 1.08
Laparoscopic orchiopexy: procedure of choice for the nonpalpable testis? J Urol (1998) 1.07
Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn (2001) 1.07
Intestinal cell radiosensitivity: a comparison for cell death assayed by apoptosis or by a loss of clonogenicity. Int J Radiat Biol Relat Stud Phys Chem Med (1982) 1.06
Pretreatment prostate-specific antigen doubling times: clinical utility of this predictor of prostate cancer behavior. Int J Radiat Oncol Biol Phys (1996) 1.06
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol (1993) 1.05
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease. J Clin Oncol (1989) 1.04
Drug and radiation sensitivity measurements of successful primary monolayer culturing of human tumor cells using cell-adhesive matrix and supplemented medium. Cancer Res (1986) 1.04
Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. BJR Suppl (1992) 1.04
Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer (1991) 1.04
Normal tissue radiobiology: from the laboratory to the clinic. Int J Radiat Oncol Biol Phys (2001) 1.04
The effects of exogenous progesterone and estradiol on prostaglandin F levels in ovariectomized ewes. Prostaglandins (1972) 1.03
Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol (1996) 1.03
Isolation and biochemical studies of enriched populations of spermatogonia and early primary spermatocytes from rat testes. Biol Reprod (1986) 1.02
Location and fate of the nonpalpable testis in children. J Urol (1983) 1.01
Lesions of Cowper's glands in children. J Urol (1979) 1.00
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo. Cancer Res (1994) 1.00
Dose and time relationships in the endocrine response of the irradiated adult rat testis. J Androl (1986) 1.00
Laparoscopic Fowler-Stephens orchiopexy for the high abdominal testis. J Urol (1999) 0.99
Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol (1986) 0.99
Models in radiotherapy: volume effects. Med Phys (1983) 0.99
Normal tissue reactions and complications following high-energy neutron beam therapy: I. Crude response rates. Int J Radiat Oncol Biol Phys (1989) 0.99
The gastrointestinal syndrome and mucosal clonogenic cells: relationships between target cell sensitivities, LD50 and cell survival, and their modification by antibiotics. Radiat Res (1983) 0.99
Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int J Radiat Oncol Biol Phys (1995) 0.99
Radiation-induced injury to the visual pathway. Radiother Oncol (1994) 0.98
Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer (2000) 0.98
The correction of intestinal microcolony counts for variation in size. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 0.97
Cryptogenic cells and proliferative cells in intestinal epithelium. Int J Radiat Biol Relat Stud Phys Chem Med (1974) 0.97
Potential methods for predicting tumor radiocurability. Int J Radiat Oncol Biol Phys (1986) 0.96
Characterization of high mobility group protein levels during spermatogenesis in the rat. J Biol Chem (1984) 0.96
Inter-tumor heterogeneity and radiation dose-control curves. Radiother Oncol (1987) 0.96
BCR rearrangement-negative chronic myelogenous leukemia revisited. J Clin Oncol (2001) 0.95
The doubling time of regenerating clonogenic cells in the crypts of the irradiated mouse small intestine. Int J Radiat Biol (1988) 0.95
Strategies for treating possible tumor extension: some theoretical considerations. Int J Radiat Oncol Biol Phys (1985) 0.95
Apoptosis in irradiated murine tumors. Radiat Res (1991) 0.95
Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res (1992) 0.95
Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys (1993) 0.95
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma. J Clin Oncol (1986) 0.94
Radionecrosis of normal tissue: studies on mouse tails. Int J Radiat Biol Relat Stud Phys Chem Med (1978) 0.94
The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by x rays. Br J Radiol (1972) 0.94
Distribution and synthesis of histone 1 subfractions during spermatogenesis in the rat. Exp Cell Res (1982) 0.93
The intrinsic radiosensitivity of normal and tumour cells. Int J Radiat Biol (1998) 0.93
Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol (2001) 0.93
Reducing the duration of mechanical ventilation: three examples of change in the intensive care unit. New Horiz (1998) 0.93